Adapting Body Reprogramming for Severe Asthma: a Feasibility Study

Sponsor
Royal Devon and Exeter NHS Foundation Trust
Study ID
NCT04980755
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Body Reprogramming — OTHER
    An educational intervention originally designed for patients with fibromyalgia.

Study Details

There are many symptoms associated with severe asthma, not all of them related to the lung. These are referred to as extra-pulmonary symptoms and their relationship with quality of life is complex. Body reprogramming (BR) is a non-drug intervention originally developed for fibromyalgia patients with the aim of improving health and wellbeing in a personalised way, with evidence-based lifestyle changes. The frequency and severity of multiple symptoms in severe asthma is similar to fibromyalgia and the investigators propose that BR may be a suitable non-drug intervention for severe asthma patients who are about to step up drug treatment. Our study aims are therefore to assess how BR may be suitable for people with severe asthma, and to adapt and optimise the programme for these people. In two phases, severe asthma patients will be recruited via a regional severe asthma clinic at the Royal Devon \& Exeter National Health Service (NHS) Trust and invited to take part in a short course of BR. In phase one, patients will be asked to attend four weekly researcher-led sessions of BR via video call and be given practice tasks to report on at the subsequent session. Questionnaires will be completed for the first and last session. At the end of BR, patients will also be invited to take part in a focus group. The data collected will inform development of the programme for phase two, which will involve recruitment of severe asthma patient who are about to start biologic drug treatment for their severe asthma

Key Dates

Start date
Jul 28, 2021
Status verified
Jan 2025
Primary completion
Jun 30, 2023
Completion
Jun 30, 2023

Study Design

Enrollment
28 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
OTHER

Arms

  • Experimental: Phase one
    Participants will be asked to attend four weekly sessions of Body Reprogramming via group video call. Each session will include up to 8 patients and will consist of a 25-30 minute live presentation
  • Experimental: Phase two
    We anticipate that participant sin phase two will complete the same intervention, but it may be somewhat modified following participant feedback in phase one.

Primary Outcome Measure

Number of Participants Taking Part Who Completed All 4 Weeks of the Course [ Time Frame: Week 4 ]

Related Studies